Table of Content


Introduction
Corovirus Disease 2019 (COVID-19) - Overview
Corovirus Disease 2019 (COVID-19) - Therapeutics Development
Corovirus Disease 2019 (COVID-19) - Therapeutics Assessment
Corovirus Disease 2019 (COVID-19) - Companies Involved in Therapeutics Development
Corovirus Disease 2019 (COVID-19) - Drug Profiles
Corovirus Disease 2019 (COVID-19) - Dormant Projects
Corovirus Disease 2019 (COVID-19) - Discontinued Products
Corovirus Disease 2019 (COVID-19) - Product Development Milestones
Appendix



List of Figures


Number of Products under Development for Coronavirus Disease 2019 (COVID-19), H2 2020
Number of Products under Development by Companies, H2 2020
Number of Products under Development by Universities/Institutes, H2 2020
Number of Products by Top 10 Targets, H2 2020
Number of Products by Stage and Top 10 Targets, H2 2020
Number of Products by Top 10 Mechanism of Actions, H2 2020
Number of Products by Stage and Top 10 Mechanism of Actions, H2 2020
Number of Products by Top 10 Routes of Administration, H2 2020
Number of Products by Stage and Top 10 Routes of Administration, H2 2020
Number of Products by Top 10 Molecule Types, H2 2020
Number of Products by Stage and Top 10 Molecule Types, H2 2020


List of Tables


Number of Products under Development for Coronavirus Disease 2019 (COVID-19), H2 2020
Number of Products under Development by Companies, H2 2020
Number of Products under Development by Universities/Institutes, H2 2020
Products under Development by Companies, H2 2020
Products under Development by Universities/Institutes, H2 2020
Number of Products by Stage and Target, H2 2020
Number of Products by Stage and Mechanism of Action, H2 2020
Number of Products by Stage and Route of Administration, H2 2020
Number of Products by Stage and Molecule Type, H2 2020
Coronavirus Disease 2019 (COVID-19) - Pipeline by 4D Pharma Plc, H2 2020
Coronavirus Disease 2019 (COVID-19) - Pipeline by A2A Pharmaceuticals Inc, H2 2020
Coronavirus Disease 2019 (COVID-19) - Pipeline by AB Science SA, H2 2020
Coronavirus Disease 2019 (COVID-19) - Pipeline by AbbVie Inc, H2 2020